These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6772024)

  • 1. Correction of I-cell defect by hybridization with lysosomal enzyme deficient human fibroblasts.
    d'Azzo A; Halley DJ; Hoogeveen A; Galjaard H
    Am J Hum Genet; 1980 Jul; 32(4):519-28. PubMed ID: 6772024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human beta-galactosidase and alpha-neuraminidase deficient mucolipidosis: genetic complementation analysis of the neuraminidase deficiency.
    Mueller OT; Shows TB
    Hum Genet; 1982; 60(2):158-62. PubMed ID: 7076257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity of I-cell disease is demonstrated by complementation of lysosomal enzyme processing mutants.
    Shows TB; Mueller OT; Honey NK; Wright CE; Miller AL
    Am J Med Genet; 1982 Jul; 12(3):343-53. PubMed ID: 6287841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion with enucleated fibroblasts corrects "I-cell" defect.
    D'Azzo A; Konings A; Verkerk A; Jongkind JF; Galjaard H
    Exp Cell Res; 1980 Jun; 127(2):484-7. PubMed ID: 6769689
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
    Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation, cross correction, and drug correction studies of combined beta-galactosidase neuraminidase deficiency in human fibroblasts.
    Strisciuglio P; Creek KE; Sly WS
    Pediatr Res; 1984 Feb; 18(2):167-71. PubMed ID: 6422434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complementation of beta-galactosidase in fused cells of mucolipidosis II with another variants of beta-galactosidase deficiency using new single cell enzyme assay.
    Okada S; Kato T; Yabuuchi H; Okada Y
    Biochem Biophys Res Commun; 1979 May; 88(2):559-62. PubMed ID: 111672
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecific genetic complementation analysis of human and sheep fibroblasts with beta-galactosidase deficiency.
    Ahern-Rindell AJ; Murnane RD; Prieur DJ
    Somat Cell Mol Genet; 1989 Nov; 15(6):525-33. PubMed ID: 2512653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of N-acetyl-beta-D-hexosaminidase from isolated normal and I-cell lysosomes.
    Miller AL; Kress BC; Stein R; Kinnon C; Kern H; Schneider JA; Harms E
    J Biol Chem; 1981 Sep; 256(17):9352-62. PubMed ID: 7263719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult type GMl-gangliosidosis: a complementation study on somatic cell hybrids.
    Suzuki Y; Furukawa T; Hoogeveen A; Verheijen F; Galjaard H
    Brain Dev; 1979; 1(2):83-6. PubMed ID: 121869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of lysosomal enzymes in human mutant fibroblast-chick erythrocyte heterokaryons.
    Van der Veer E; Barneveld RA; Reuser AJ
    Exp Cell Res; 1982 Nov; 142(1):235-45. PubMed ID: 6291965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of sucrose loading on lysosomal hydrolases.
    Kato T; Okada S; Yutaka T; Yabuuchi H
    Mol Cell Biochem; 1984; 60(1):83-98. PubMed ID: 6708943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic abnormalities of lysosomal enzymes in mucolipidosis fibroblast lines.
    Champion MJ; Shows TB
    Am J Hum Genet; 1977 Mar; 29(2):149-63. PubMed ID: 848490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro establishment of human fibroblasts of lysosomal diseases, GM1-gangliosidosis and Sandhoff disease, by transformation with origin-minus SV40 DNA.
    Momoi T; Furuya T; Suzuki Y; Sato H; Yamaguchi N
    Biosci Rep; 1985 Mar; 5(3):267-73. PubMed ID: 2990594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of lysosomal enzymes in cultured normal and sialidosis type II human fibroblasts and the effect of ammonium chloride on this heterogeneity.
    Heyworth CM; Wynn CH
    Mol Cell Biochem; 1985 May; 67(1):25-30. PubMed ID: 3160928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis.
    Mueller OT; Honey NK; Little LE; Miller AL; Shows TB
    J Clin Invest; 1983 Sep; 72(3):1016-23. PubMed ID: 6309902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementation studies with enucleated fibroblasts from different variants of beta-galactosidase deficiency.
    de Wit-Verbeek HA; Hoogeveen A; Galjaard H
    Exp Cell Res; 1978 Apr; 113(1):215-8. PubMed ID: 416963
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoelectron microscopical localization of lysosomal beta-galactosidase and its precursor forms in normal and mutant human fibroblasts.
    Willemsen R; Hoogeveen AT; Sips HJ; van Dongen JM; Galjaard H
    Eur J Cell Biol; 1986 Mar; 40(1):9-15. PubMed ID: 3084261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.